The Discounted Cash Flow (DCF) valuation of Valeo Pharma Inc (VPH.CN) is (112.86) CAD. With the latest stock price at 0.59 CAD, the upside of Valeo Pharma Inc based on DCF is -19228.3%.
Based on the latest price of 0.59 CAD and our DCF valuation, Valeo Pharma Inc (VPH.CN) is a sell. selling VPH.CN stocks now will result in a potential gain of 19228.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 9.2% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (346.85) - (67.60) | (112.86) |
| Upside | -58887.9% - -11557.3% | -19228.3% |